Keloid pathogenesis
occurs due to the longer duration of inflammation and the increase in the
production of several factors such as TGF-β1
that causes the increase of fibroblast proliferation and collagen synthesis.
The role of B4 Leukotriene (LTB4) in keloid pathogenesis particularly in the
inflammation phase and tissue proliferation has not been clearly elucidated. The present study was to analyze the levels
of LTB4, TGF-β1 and collagen in
keloid fibroblast and normal skin fibroblast. Fibroblasts were cultured by
applying explant method to the keloid and normal skin of the petient with the
keloid. The measurement of the levels of LTB4, TGF-β1 and collagen was conducted by using Elisa method and
triplicate was conducted subsequently. Statistic testing was performed through
unpaired t test. The experiment was carried out in cell culture laboratory of
The Faculty of Medicine Padjajaran University Bandung. The levels of LTB4, TGF-β1 are higher in keloid fibroblast,
despite the fact that it does not show statistically significant difference.
The level of collagen 1 is higher than that of collagen 3 in keloid fibroblast.
Leukotriene B4 (LTB4) is one of the derivative of arachidonic acid that plays
the role as lipid mediumtor of inflammation and fibroblast chemoattractant. The
levels of LTB4, TGF-β1, collagen 1
and collagen 3 increase in keloid fibroblast. Such a result shows the role of
LTB4 in the inflammation process that stretches in keloid pathogenesis.
Cite this paper
Kurniawati, Y. , Suwarsa, O. , Agung, A. and Adi, S. (2016). The Comparison of the Levels of Leukotriene B4, TGF-β1, Collagen in Keloid Fibroblasts and Normal Skin Fibroblast. Open Access Library Journal, 3, e2801. doi: http://dx.doi.org/10.4236/oalib.1102801.
Dolores, W.,
Tzankov, A.,
Pulzi, P. and Hildegunde, P.K. (2009)
Hypertrophic Scar and Keloids—A Review of Their Pathophysiology, Risk Factors,
and Therapeutic Management. Dermatologic
Surgery, 35, 171-181. http://dx.doi.org/10.1111/j.1524-4725.2008.34406.x
Bran, G.M.,
Goessler, U.R.,
Hormann, K.,
Riedel, F. and
Sadick, H. (2009)
Keloids: Current Concepts of Pathogenesis (Review). International Journal of Molecular Medicine, 24, 283-293.
Satori, V.F. (2012)
Mechanisms of Wound Repair, Wound Healing and Wound Dressing. In: Goldsmith, L.A., Katz, S.I.,
Gilchrest, B.A.,
Paller, A.S.,
Leffell, D.J.,
Wolff, K., Eds., Fitzpatrick’s Dermatology in General Medicine, 8th Edition, Mc GrawHill, New York, 2984-2994.
Profyris, C.,
Christos, T. and
Isabel, D.V. (2012)
Cutaneous Scarring: Pathophysiology, Molecular Mechanisms, and Scar Reduction
Therapeutics Part I. The Molecular Basis of Scar Formation. Journal of the American Academy of Der- matology, 66, 1-10. http://dx.doi.org/10.1016/j.jaad.2011.05.055
Scheml, S., Rolf
Markus, S.,
Prantl, L.,
Landthaler, M. and Babilas, P. (2010) Wound Healing
in the 21st Century. Journal of the American Academy of Dermatology, 63, 866-881. http://dx.doi.org/10.1016/j.jaad.2009.10.048
Sadik, C.D. and Luster, A.D. (2012)
Lipid-Cytokine-Chemokine Cascade Orcherstrate Leukocyte Recruitment in Inflammation. Journal of Leukocyte Biology, 91,
207-315. http://dx.doi.org/10.1189/jlb.0811402
Sharma, J.N. and
Mohammed, L.A. (2006) The
Role of Leukotrienes in the Pathophysiology of Inflammatory Disorders: Is There
a Case for Revisiting Leukotriene as Therapeutic Targets? Inflammopharmacology, 14, 10-16. http://dx.doi.org/10.1007/s10787-006-1496-6
Louw, L. (2000)
Keloids in Rural black South Africans. Part 1: General Overview and Essential
Fatty Acid Hypotheses for Keloid Formation and Prevention. Prostaglandins, Leukotrienes
and Essential Fatty Acids, 63, 237-245. http://dx.doi.org/10.1054/plef.2000.0207
Izumo, T.,
Kondo, M., Arai, N. and Nagai, A. (2010) Role
of Leukotriene B4 Reseptor Antagonist in Pulmonal Fibrosis. Annals of Respiratory Medicine, 1-5.
Sylwia, C.,
Krzysztof, K., Marek, B. and
Otylia, K.B. (2012) The
Role of Leukotrienes in the Pathogenesis of Systemic Sclerosis. Folia Histochemica et Cytobiologica, 50, 180-185. http://dx.doi.org/10.5603/FHC.2012.0027
Biren, N.S.,
Nitin, P.P. and
Priyanka, P. (2008) Role
of Leukotriene in
Inflammation and Antileukotriene Therapy. Journal
of Pharmacy Research, 1,
113-125.
Vanina, M.T.V., Bernardo, H., Jeronimo, P.F. and Lydia, M.F. (2010) Keloid Explant, Culture: A Model for Keloid
Fibroblasts Isolation and Cultivation Based on the Biological Differences of
Its Specific Regions. International Wound
Journal, 7, 339-348. http://dx.doi.org/10.1111/j.1742-481X.2010.00698.x
Syed, F.,
Ahmadi, E., Iqbal,
S.A., Singh, S., McGrouther,
D.A. and Bayat, A. (2011)
Fibroblast from the Growing Margin of Keloid Scars Produce Higher Levels of
Collagen I and III Compared with Intralesional and Extralesional Sites: Clinical
Implications for Lesional Site-Directed Therapy. British Journal of Dermatology, 164, 83-96. http://dx.doi.org/10.1111/j.1365-2133.2010.10048.x
Jie, L.,
Zuleika, L.B.M. and
Robert, S.K. (2010) Wound
Healing. In:
Robinson, J.K.,
William, H.,
Daniel, M.S. and Alina, F., Eds., Surgery of the Skin: Prosedural Dermatology, 2nd Edition, Mosby, Maryland Heights, 95-109.
Xiao, J.W.,
Gangwen, H.,
Philip, O.,
Yasmin, S. and Allen, G.L. (2006) Role
of TGFβ-Mediated Inflammation in Cutaneous Wound Healing. Journal of Investigative Dermatology
Symposium Proceedings, 11, 112-117. http://dx.doi.org/10.1038/sj.jidsymp.5650004
Thomas, A.W. (2007)
Common and Unique Mechanisms Regulate Fibrosis in Various Fibroproliferative Diseases. The Journal of Clinical Investigation, 117, 524-529. http://dx.doi.org/10.1172/JCI31487
Wedi, B. and
Kapp, A. (2001)
Pathophysiologic Role of Leukotrienes in Dermatological Diseases, Potential
Thera- peutic
Implications. BioDrugs, 15, 729-743. http://dx.doi.org/10.2165/00063030-200115110-00004
Marry, B.,
Robert, D. and
Noelynn, O. (1992)
Keloid Fibroblast Exhibit an Altered Response to TGF-β. Journal of Investigative
Dermatology, 99, 650-655.
